N2N Technologies: Harmony Remedies launches 40% open offer at ₹4.30

TECH
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
N2N Technologies: Harmony Remedies launches 40% open offer at ₹4.30
Overview

Harmony Remedies India Private Limited is making a public open offer to acquire up to 40% of N2N Technologies Ltd for ₹4.30 per share. This move, triggered by an Acquisition of Control Agreement, comes as N2N's shares are trading substantially higher than the offer price, presenting a potential exit for shareholders. The offer marks a significant step towards a potential change of control at the IT services firm.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Harmony Remedies Launches 40% Open Offer for N2N Technologies at Deep Discount

Harmony Remedies India Private Limited, along with its Persons Acting in Concert (PACs), has announced an open offer to acquire up to 12,91,228 equity shares of N2N Technologies Ltd. This represents 40% of the company's expanded voting capital, offered at a price of ₹4.30 per share. The public announcement was made on April 29, 2026, following a SEBI observation letter dated April 13, 2026.

Intent to Acquire Control

This open offer signals a clear intent to acquire control of N2N Technologies. For minority shareholders, it presents an exit route. However, the offer price of ₹4.30 is significantly below N2N Technologies' current market valuation, potentially offering a substantial discount for consolidating ownership or changing the company's direction.

Acquisition Background

The open offer stems from an Acquisition of Control Agreement (ACA) signed on October 27, 2025, between Harmony Remedies India Private Limited and N2N Technologies. Harmony Remedies, incorporated on May 29, 2023, is primarily engaged in wholesale trade. N2N Technologies, an IT services firm established in 1985, had its shares suspended from trading prior to this announcement, with a revocation application filed.

Shareholder Options and Potential Changes

Shareholders have the option to tender their shares at ₹4.30 per share. If the offer is fully subscribed, Harmony Remedies and its PACs will hold a significant stake, potentially leading to changes in management and strategic direction for N2N Technologies.

Key Risks for Shareholders

The primary risk for shareholders is the deep discount of the offer price (₹4.30) compared to N2N Technologies' recent market trading prices, which have ranged between approximately ₹29 to ₹32. Other risks include the success rate of the offer and the acquirer's future plans, especially given Harmony Remedies' limited operational history and its different business focus (wholesale trade versus IT services).

Industry Context

N2N Technologies operates in the IT consulting and software sector. While N2N is a small-cap IT firm with a market capitalization around ₹10-11 crore, its peers in the broader Indian IT services space include much larger entities like Infosys and TCS, as well as other smaller players. The current offer price of ₹4.30 is markedly lower than the recent trading prices seen by N2N Technologies itself.

Key Metrics and Dates

  • N2N Technologies Ltd. share price as of April 25, 2026, was approximately ₹31.40.
  • N2N Technologies Ltd. share price as of April 15, 2026, was approximately ₹29.92.

What to Track Next

Key next steps for investors to track include the opening and closing dates of the open offer, the acceptance rate, any further regulatory approvals or announcements from SEBI or the exchanges, and Harmony Remedies' post-offer plans for N2N Technologies' business and management. The future trading status of N2N Technologies' shares will also be important.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.